STADRIUS
LIVE

Serial Number

79253529

Owner

NOVARTIS AG

Filing Date

Dec 24, 2018

Add to watchlist:

No watchlists yet
View on USPTO

STADRIUS Trademark

Serial Number: 79253529 • Registration: 5802940

STADRIUS is a trademark filed by NOVARTIS AG on December 24, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

December 24, 2018

Registration Date

July 16, 2019

Published for Opposition

April 30, 2019

Cancellation Date

November 23, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Dec 10, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Dec 10, 2022 DETH
NOTIFICATION PROCESSED BY IB
Sep 27, 2019 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Sep 5, 2019 FICS
FINAL DISPOSITION PROCESSED
Sep 5, 2019 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Aug 15, 2019 GPAR
REGISTERED-PRINCIPAL REGISTER
Jul 16, 2019 R.PR
PUBLISHED FOR OPPOSITION
Apr 30, 2019 PUBO
NOTICE OF PUBLICATION
Apr 10, 2019 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 19, 2019 CNSA
ASSIGNED TO EXAMINER
Mar 18, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 15, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 11, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 7, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 7, 2019 REPR